Commercial disclosure
The CoreAge relationship, the first placement and the article links used by Fifty, In Focus.
Why CoreAge appears first
Fifty, In Focus belongs to the CoreAge Rx promotional publishing network. CoreAge has the first commercial position in provider reading and the comparison. This does not establish clinical superiority, age-specific benefit or a personal recommendation.
The article feature
After two introductory paragraphs, each article includes a marked CoreAge feature. It offers the local review and a link to the current Smooth Move offer. That outbound link carries sponsored and nofollow attributes with four public campaign values identifying the publication, referral medium, product and article.
What is not established
We do not claim a particular legal ownership structure, specific commission, clinician endorsement, firsthand test or independently verified care outcome. Compounded medicines are not FDA approved. Promotional placement does not resolve the ingredients or amount in a reader’s actual prescription.
Leaving the publication
External websites have their own assessment, privacy and commercial processes. Our public-source review does not verify patient intake, payment, shipping, dispensing or clinical follow-up. Reading an offer should not be confused with a professional evaluation.